These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 12595849

  • 1. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
    Gavazzi A, Ghio S, Scelsi L, Campana C, Klersy C, Serio A, Raineri C, Tavazzi L.
    Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849
    [Abstract] [Full Text] [Related]

  • 2. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
    Gavazzi A, Berzuini C, Campana C, Inserra C, Ponzetta M, Sebastiani R, Ghio S, Recusani F.
    J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
    [Abstract] [Full Text] [Related]

  • 3. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W, Costard-Jaeckle A, Stempfle HU, Deng MC, Schwaab B, Haaff B, Naegele H, Mohacsi P, Trautnitz M, PROPHET Study Group.
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [Abstract] [Full Text] [Related]

  • 5. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.
    Goland S, Czer LS, Kass RM, De Robertis MA, Mirocha J, Coleman B, Capelli C, Raissi S, Cheng W, Fontana G, Trento A.
    J Heart Lung Transplant; 2007 Apr; 26(4):312-8. PubMed ID: 17403470
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
    Braun S, Schrötter H, Schmeisser A, Strasser RH.
    Int J Cardiol; 2007 Jan 31; 115(1):67-72. PubMed ID: 16797747
    [Abstract] [Full Text] [Related]

  • 7. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
    Schwartzenberg S, Redfield MM, From AM, Sorajja P, Nishimura RA, Borlaug BA.
    J Am Coll Cardiol; 2012 Jan 31; 59(5):442-51. PubMed ID: 22281246
    [Abstract] [Full Text] [Related]

  • 8. The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones?
    Gardner RS, Henderson G, McDonagh TA.
    J Heart Lung Transplant; 2005 Mar 31; 24(3):303-9. PubMed ID: 15737757
    [Abstract] [Full Text] [Related]

  • 9. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P, Parry G, Dark JH, Macgowan GA.
    J Heart Lung Transplant; 2009 Jul 31; 28(7):676-82. PubMed ID: 19560695
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Short-term survival after heart transplantation: the relationships between preoperative hemodynamics, organ function and postoperative clinical events].
    Frigerio M, Gronda E, Danzi GB, Mangiavacchi M, Oliva F, Quaini E, Trotta E, De Vita C, Pellegrini A.
    G Ital Cardiol; 1995 Jan 31; 25(1):1-9. PubMed ID: 7642005
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pulmonary vasodilation after heart transplantation. A comparison among prostacyclin, sodium nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity.
    Kieler-Jensen N, Milocco I, Ricksten SE.
    J Heart Lung Transplant; 1993 Jan 31; 12(2):179-84. PubMed ID: 8476888
    [Abstract] [Full Text] [Related]

  • 14. Prognostic evaluation of ambulatory patients with advanced heart failure.
    Mullens W, Abrahams Z, Skouri HN, Taylor DO, Starling RC, Francis GS, Young JB, Tang WH.
    Am J Cardiol; 2008 May 01; 101(9):1297-302. PubMed ID: 18435961
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction.
    Missant C, Rex S, Segers P, Wouters PF.
    Crit Care Med; 2007 Mar 01; 35(3):707-15. PubMed ID: 17255859
    [Abstract] [Full Text] [Related]

  • 17. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT, Paraskevaidis I, Bistola V, Farmakis D, Panou F, Kourea K, Nikolaou M, Filippatos G, Kremastinos D.
    Am J Cardiol; 2006 Dec 01; 98(11):1489-92. PubMed ID: 17126656
    [Abstract] [Full Text] [Related]

  • 18. The Munich score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies.
    Stempfle HU, Alt A, Stief J, Siebert U.
    J Heart Lung Transplant; 2008 Feb 01; 27(2):222-8. PubMed ID: 18267231
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension.
    Chen EP, Bittner HB, Davis RD, Van Trigt P.
    Ann Thorac Surg; 1997 Jun 01; 63(6):1546-55. PubMed ID: 9205146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.